Aug 2021: Wuxi AppTec immune profiling in drug discovery and CLDN18.2-related tumor models.

View Now
← Return to Resources

Related Content

Leverage our extensive panel of rat xenograft and syngeneic tumor models. Advantages for using rats in preclinical efficacy studies compared...

VIEW RESOURCE
← View all Candidate Selection Resources
× peptide, amino acid

Contact An Expert Today!